[Theory and practice of daily prescription and gynecologic consultation for treatment of hyperandrogenism. Indications and contraindications].
Vexiau
P
P
Service d'endocrinologie-diabétologie, Hôpital Saint-Louis, Paris, France.
D000726:Androgen Antagonists / Q000009:adverse effects / Q000627:therapeutic use*; D017373:Cyproterone Acetate / Q000009:adverse effects / Q000627:therapeutic use*; D004967:Estrogens / Q000009:adverse effects / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D017588:Hyperandrogenism / Q000628:therapy*; D011372:Progestins / Q000009:adverse effects / Q000627:therapeutic use*
D000726:Androgen Antagonists; D004967:Estrogens; D011372:Progestins; D017373:Cyproterone Acetate